ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Amlan International to Exhibit and Present at the XXVII Central American and Caribbean Poultry Congress in Panama City

CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Amlan International, the animal health business of Oil-Dri® Corporation of America and a global leader in mineral-based feed additives, will showcase its innovative solutions for antibiotic-free production at XXVII CENTRAL AMERICAN AND CARIBBEAN POULTRY CONGRESS – PANAMA 2025, September 10–12, at the Panama Convention Center in Panama City, Panama. Attendees can connect with the Amlan team at Booth 15 to learn more about the company’s proven technologies for improving animal health and performance.

A highlight of Amlan’s participation will be a technical presentation by Dr. César Coto, Amlan’s Technical Director for LATAM. On Thursday, September 11, from 12:45 p.m. to 1:30 p.m. in the Nutrition track (Pacific Rooms 4 and 5), Dr. Coto will present “Adaptations in Management Programs to Reduce Antibiotic Use.” This session will explore practical strategies for producers looking to reduce or eliminate antibiotics in livestock production while maintaining animal performance, with a focus on optimizing gut health through effective natural solutions.

“Latin America’s livestock industry is rapidly evolving, with increasing emphasis on antibiotic stewardship and the demand for safe, high-quality animal protein,"said Heath Wessels, Vice President of Sales, The Americas.“Events like the XXVII Central American and Caribbean Poultry Congress are critical opportunities to share science-based innovations that help producers meet challenges while achieving strong business results.”

At Booth 15, Amlan will feature Calibrin®-Z, a broad-spectrum biotoxin control product that binds both mycotoxins and toxins from pathogenic bacteria, and Varium®, a gut health additive designed to improve intestinal integrity, reduce the impact of pathogenic bacteria, and enhance feed efficiency—especially in antibiotic-free production systems. Visitors will also be able to learn more about Amlan’s mineral-based technology, which leverages the unique properties of its proprietary calcium montmorillonite to deliver consistent, proven performance in the field.

“As Amlan deepens its focus in the Central American market, we’re proud to offer producers natural solutions that support animal health and performance,” said Dr. Robin Jaquin, Regional Director of Latin America. “The growth in livestock and poultry production highlights how Central American producers are embracing innovation. By integrating advanced feed additives, we’re helping producers improve animal health, enhance efficiency, and meet the region’s rising demand for high-quality protein.”

Attendees are invited to visit the Amlan booth to engage with our team and learn more about how science-backed solutions can help support their operations.

About Amlan International
Amlan International, the animal health business of Oil-Dri® Corporation of America (NYSE: ODC), develops and markets innovative, natural feed additives that optimize animal health and performance. Oil-Dri Corporation of America, founded in 1941, is a global leader in sorbent mineral technology. For more information, visit www.Amlan.com.

Contact:
Reagan Culbertson, Vice President of Strategic Marketing, B2B
Reagan.culbertson@amlan.com 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/65d657d5-02ef-4e6d-b30f-657a3e5a876e


Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.